An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Patients Treated with the Abbott TriClipTM Device

Recruiting

• Conditions: leakage of the heartvalve; Tricuspid regurgitation; 10046973

• Registration Number: NL-OMON54878
• Lead Sponsor: St. Jude Medical

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 15

Inclusion Criteria

1. Subjects (>=18 years age) have severe tricuspid regurgitation and are
symptomatic despite
medical therapy.
2. Subjects eligible to receive the TriClip* per the current approved intended
use and target patient
population.
3. Subject must provide written informed consent prior to study procedure.

Exclusion Criteria

1. Subjects participating in another clinical study that may impact the
follow-up or results of this
study.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified